CAS 130714-47-5

SDZWAG994

Description:

The chemical substance identified by the name "SDZWAG994" and CAS number "130714-47-5" is a synthetic compound that falls under the category of small molecules. While specific characteristics such as its molecular formula, structure, and physical properties are not widely documented in public databases, compounds with similar identifiers typically exhibit unique biological activities or applications in fields such as pharmaceuticals or materials science. The CAS number indicates that it is a well-defined chemical entity, which suggests that it may have been studied for its potential uses, possibly in drug development or as a research tool. To obtain detailed information about its characteristics, including solubility, stability, and reactivity, one would typically refer to specialized chemical databases, scientific literature, or safety data sheets. It is essential to consult these resources for comprehensive data, especially for applications involving safety and handling.

Formula: C₁₇H₂₅N₅O₄

InChI: InChI=1/C17H25N5O4/c1-25-14-13(24)11(7-23)26-17(14)22-9-20-12-15(18-8-19-16(12)22)21-10-5-3-2-4-6-10/h8-11,13-14,17,23-24H,2-7H2,1H3,(H,18,19,21)/t11-,13-,14-,17-/m1/s1

SMILES: CO[C@@H]1[C@@H]([C@@H](CO)O[C@H]1n1cnc2c(ncnc12)NC1CCCCC1)O

Synonyms:

• N(6)-cyclohexyl-2-O-methyladenosine
• N-cyclohexyl-2'-O-methyladenosine

Adenosine, N-cyclohexyl-2'-O-methyl-

CAS: 130714-47-5

Formula: C₁₇H₂₅N₅O₄

Purity: 98%

Color and Shape: Solid

Molecular weight: 363.4115

Ref: IN-DA000UV0

SDZ WAG 994

CAS: 130714-47-5

SDZ WAG 994

Purity: ≥98%

Molecular weight: 363.41g/mol

Ref: 54-BUP08292

SDZ WAG 994

CAS: 130714-47-5

SDZ WAG 994 is an A1 adenosine receptor agonist.

Formula: C₁₇H₂₅N₅O₄

Purity: 99.82%

Color and Shape: Solid

Molecular weight: 363.41

Ref: TM-T23347

SDZ WAG 994

CAS: 130714-47-5

SDZ WAG 994 is an experimental drug that has been shown to reduce the incidence of diabetic cardiomyopathy. It is a small molecule with a molecular weight of 514.3 Da and an adenosine receptor agonist activity. SDZ WAG 994 binds to adenosine receptors, which are found in the heart and brain. These receptors are involved in locomotion, pain sensation, and cardiac function. The binding of SDZ WAG 994 to these receptors leads to increased levels of cAMP, which is necessary for cell growth and proliferation. In addition, SDZ WAG 994 has been shown to have anti-inflammatory properties that may be useful in treating chronic pain caused by damaged tissue.
SDZ WAG 994 was evaluated as a treatment for ventricular dysfunction in patients with type 2 diabetes mellitus (T2DM) using a randomized controlled trial design in which subjects were given either placebo or 50 mg/day of SDZ WAG 9

Formula: C₁₇H₂₅N₅O₄

Purity: Min. 95%

Molecular weight: 363.41 g/mol

Ref: 3D-FFA71447